Screener
Marker Therapeutics, Inc. MRKR Q4 2025 Annual earnings
Reported March 18, 2026 · Before market open
Revenue$1.1MBeat by $417.9K
EPS-$0.04Beat by $0.17
Revenue estimate$682.1K
EPS estimate-$0.21
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$2.1M
EPS estimate-$0.12
Versus estimates
Revenue
Q4 2025$1.1MBeat by $417.9K
Q3 2025$1.2MBeat by $509.9KQ2 2025$861.2KBeat by $430.6KQ1 2025$349.1KBeat by $174.6KDiluted EPS
FAQ
- When did Marker Therapeutics, Inc. report Q4 2025 earnings?
- Marker Therapeutics, Inc. (MRKR) reported Q4 2025 earnings on March 18, 2026 before market open.
- What were Marker Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Marker Therapeutics, Inc. reported revenue of $1.1M and eps of $-0.04 for Q4 2025.
- Did Marker Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $682.1K by $417.9K. EPS beat the consensus estimate of $-0.21 by $0.17.
- How did Marker Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 51.1% from $2.3M a year earlier and eps grew 90.5% from $-0.42.
- Where can I find Marker Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-26-031309) and the 10-K periodic report (0001104659-26-031274) directly on SEC EDGAR. The filing index links above go to sec.gov.
